Counting the cost of caplacizumab

被引：16
作者：
Chaturvedi, Shruti [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
BLOOD | 2021年 / 137卷 / 07期
关键词：
DEATH;
D O I：
10.1182/blood.2020009250
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Goshua et al present a timely cost-effectiveness analysis of caplacizumab for immune thrombotic thrombocytopenic purpura (iTTP) and conclude that adding caplacizumab to standard-of-care (SOC) therapy with plasma exchange and immunosuppression is not cost-effective based on outcomes including duration of hospitalization and iTTP recurrence.(1)
引用
收藏
页码：871 / 872
页数：2
相关论文
共 10 条
  • [1] Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
    Benhamou, Ygal
    Assie, Cyrielle
    Boelle, Pierre-Yves
    Buffet, Marc
    Grillberger, Rana
    Malot, Sandrine
    Wynckel, Alain
    Presne, Claire
    Choukroun, Gabriel
    Poullin, Pascale
    Provot, Francois
    Gruson, Didier
    Hamidou, Mohamed
    Bordessoule, Dominique
    Pourrat, Jacques
    Mira, Jean-Paul
    Le Guern, Veronique
    Pouteil-Noble, Claire
    Daubin, Cedric
    Vanhille, Philippe
    Rondeau, Eric
    Palcoux, Jean-Bernard
    Mousson, Christiane
    Vigneau, Cecile
    Bonmarchand, Guy
    Guidet, Bertrand
    Galicier, Lionel
    Azoulay, Elie
    Rottensteiner, Hanspeter
    Veyradier, Agnes
    Coppo, Paul
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1181 - 1186
  • [2] TTP: long-term outcomes following recovery
    George, James N.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 548 - 552
  • [3] Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
    Goshua, George
    Sinha, Pranay
    Hendrickson, Jeanne E.
    Tormey, Christopher
    Bendapudi, Pavan K.
    Lee, Alfred Ian
    [J]. BLOOD, 2021, 137 (07) : 969 - 976
  • [4] How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns
    Mazepa, Marshall A.
    Masias, Camila
    Chaturvedi, Shruti
    [J]. BLOOD, 2019, 134 (05) : 415 - 420
  • [5] Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura
    Peyvandi, F.
    Scully, M.
    Hovinga, J. A. Kremer
    Knoebl, P.
    Cataland, S.
    De Beuf, K.
    Callewaert, F.
    De Winter, H.
    Zeldin, R. K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (07) : 1448 - 1452
  • [6] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
    Scully, M.
    Cataland, S. R.
    Peyvandi, F.
    Coppo, P.
    Knobl, P.
    Hovinga, J. A. Kremer
    Metjian, A.
    de la Rubia, J.
    Pavenski, K.
    Callewaert, F.
    Biswas, D.
    De Winter, H.
    Zeldin, R. K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04) : 335 - 346
  • [7] The high cost of prescription drugs: causes and solutions
    Vincent Rajkumar, S.
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (06)
  • [8] ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
    Voelker, Linus A.
    Kaufeld, Jessica
    Miesbach, Wolfgang
    Braehler, Sebastian
    Reinhardt, Martin
    Kuehne, Lucas
    Muehlfeld, Anja
    Schreiber, Adrian
    Gaedeke, Jens
    Toelle, Markus
    Jabs, Wolfram J.
    Ozcan, Fedai
    Markau, Silke
    Girndt, Matthias
    Bauer, Frederic
    Westhoff, Timm H.
    Felten, Helmut
    Hausberg, Martin
    Brand, Marcus
    Gerth, Jens
    Bieringer, Markus
    Bommer, Martin
    Zschiedrich, Stefan
    Schneider, Johanna
    Elitok, Saban
    Gawlik, Alexander
    Gaeckler, Anja
    Kribben, Andreas
    Schwenger, Vedat
    Schoenermarck, Ulf
    Roeder, Maximilian
    Radermacher, Joerg
    Bramstedt, Joern
    Morgner, Anke
    Herbst, Regina
    Harth, Ana
    Potthoff, Sebastian A.
    von Auer, Charis
    Wendt, Ralph
    Christ, Hildegard
    Brinkkoetter, Paul T.
    Menne, Jan
    [J]. BLOOD ADVANCES, 2020, 4 (13) : 3093 - 3101
  • [9] Ways and Means Committee, PAINF PILL SWALL US
  • [10] ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
    Zheng, X. Long
    Vesely, Sara K.
    Cataland, Spero R.
    Coppo, Paul
    Geldziler, Brian
    Iorio, Alfonso
    Matsumoto, Masanori
    Mustafa, Reem A.
    Pai, Menaka
    Rock, Gail
    Russell, Lene
    Tarawneh, Rawan
    Valdes, Julie
    Peyvandi, Flora
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2496 - 2502
1